Human pluripotent stem cells in regenerative medicine: where do we stand?

被引:6
|
作者
Ha Thi Nguyen [1 ]
Jacobs, Kurt [2 ]
Spits, Claudia [3 ]
机构
[1] Duy Tan Univ, Ctr Mol Biol, Inst Res & Dev, Danang, Vietnam
[2] Univ Zurich UZH, Inst Mol Canc Res, Zurich, Switzerland
[3] Vrije Univ Brussel, Res Grp Reprod & Genet, Fac Med & Pharm, Brussels, Belgium
关键词
LINEAGE-SPECIFIC DIFFERENTIATION; COPY-NUMBER; NUCLEAR TRANSFER; POINT MUTATIONS; MACULAR DEGENERATION; GENOMIC INSTABILITY; TERATOMA FORMATION; CODING MUTATIONS; SOMATIC-CELLS; BETA-CELLS;
D O I
10.1530/REP-18-0291
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human pluripotent stem cells have the capacity to self-renew indefinitely and the ability to differentiate into all cell types of a human body. These characteristics instill them with an enormous promise in regenerative medicine, where they could be used in cell, tissue and even organ-based replacement therapy. In this review, we discuss their potential clinical applications and the advantages and pitfalls for the different types of human pluripotent stem cells to transition from the bench to the bedside. We provide an overview of the current clinical trials, and the specific challenges we are still facing, including immune compatibility, suboptimal differentiation, risk of tumor formation and genome instability.
引用
收藏
页码:R143 / R153
页数:11
相关论文
共 50 条
  • [1] Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
    Trigo, Catarina M.
    Rodrigues, Joana S.
    Camoes, Sergio P.
    Sola, Susana
    Miranda, Joana P.
    JOURNAL OF ADVANCED RESEARCH, 2025, 70 : 103 - 124
  • [2] Tissue engineering and regenerative medicine -where do we stand?
    Horch, Raymund E.
    Kneser, Ulrich
    Polykandriotis, Elias
    Schmidt, Volker J.
    Sun, Jiaming
    Arkudas, Andreas
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (06) : 1157 - 1165
  • [3] Pituitary stem cells: Where do we stand?
    Vankelecom, Hugo
    Chen, Jianghai
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 385 (1-2) : 2 - 17
  • [4] Culturing human pluripotent stem cells for regenerative medicine
    Ozawa, Hiroki
    Matsumoto, Takuya
    Nakagawa, Masato
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, : 479 - 489
  • [5] Human Pluripotent Stem Cells in Regenerative and Personalized Medicine
    Dittmar, Thomas
    Rossbach, Michael
    CURRENT MOLECULAR MEDICINE, 2013, 13 (05) : 691 - 694
  • [6] Regenerative Medicine Applied to Solid Organ Transplantation: Where Do We Stand?
    Orlando, G.
    Di Cocco, P.
    D'Angelo, M.
    Clemente, K.
    Famulari, A.
    Pisani, F.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) : 1011 - 1013
  • [7] Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?
    Ebert, Antje D.
    Diecke, Sebastian
    Chen, Ian Y.
    Wu, Joseph C.
    EMBO MOLECULAR MEDICINE, 2015, 7 (09) : 1090 - 1103
  • [8] Human in vitro spermatogenesis as a regenerative therapy — where do we stand?
    Meghan Robinson
    Sydney Sparanese
    Luke Witherspoon
    Ryan Flannigan
    Nature Reviews Urology, 2023, 20 : 461 - 479
  • [9] Human in vitro spermatogenesis as a regenerative therapy - where do we stand?
    Robinson, Meghan
    Sparanese, Sydney
    Witherspoon, Luke
    Flannigan, Ryan
    NATURE REVIEWS UROLOGY, 2023, 20 (08) : 461 - 479
  • [10] Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?
    Lopes, Carla
    Cristina Rego, A.
    MOLECULAR NEUROBIOLOGY, 2017, 54 (03) : 1858 - 1873